Endoscopic treatment of chronic pancreatitis.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 15980744)

Published in Gastroenterol Clin Biol on May 01, 2005

Authors

Eric Bartoli1, Richard Delcenserie, Thierry Yzet, Franck Brazier, Guillaume Geslin, Jean-Marc Regimbeau, Jean-Louis Dupas

Author Affiliations

1: Service d'Hépato-Gastroentérologie, CHU Hôpital Nord, Amiens. bartoli.eric@chu-amiens.fr

Articles by these authors

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet (2012) 5.12

Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology (2011) 3.81

Simplified staging for hepatocellular carcinoma. J Clin Oncol (2002) 3.48

Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Gastroenterology (2013) 3.45

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology (2011) 3.08

Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial. Gastroenterology (2006) 2.91

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med (2011) 2.44

Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc (2003) 2.07

Factors associated with clinically significant anastomotic leakage after large bowel resection: multivariate analysis of 707 patients. World J Surg (2002) 1.97

Simultaneous gastric band removal and sleeve gastrectomy: a comparison with front-line sleeve gastrectomy. Obes Surg (2012) 1.97

A simple biological score for predicting low risk of short-term relapse in Crohn's disease. Inflamm Bowel Dis (2006) 1.70

Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol (2005) 1.53

Saccharomyces boulardii does not prevent relapse of Crohn's disease. Clin Gastroenterol Hepatol (2013) 1.50

Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae. Ann Surg (2009) 1.47

Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr (2005) 1.45

Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg (2008) 1.41

Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study. Eur J Gastroenterol Hepatol (2005) 1.36

The small remnant liver after major liver resection: how common and how relevant? Liver Transpl (2003) 1.35

Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg (2002) 1.35

The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol (2009) 1.29

Is stenting as "a bridge to surgery" an oncologically safe strategy for the management of acute, left-sided, malignant, colonic obstruction? A comparative study with a propensity score analysis. Ann Surg (2013) 1.23

Case report-complex management of a postoperative bronchogastric fistula after laparoscopic sleeve gastrectomy. Obes Surg (2008) 1.22

Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut (2013) 1.22

Colonic pseudolipomatosis: clinical, endoscopical and pathological features in nine cases. Gastroenterol Clin Biol (2006) 1.17

Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol (2002) 1.16

Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration. Int J Cancer (2012) 1.14

Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study. Am J Gastroenterol (2006) 1.13

Results of laparoscopic sleeve gastrectomy: a prospective study in 135 patients with morbid obesity. Surgery (2008) 1.07

Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol. Gut (2012) 1.03

[Cutaneous fistulization of a liver hydatid cyst]. Gastroenterol Clin Biol (2005) 1.00

BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma. Mol Cancer Res (2010) 1.00

Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation. Hum Genet (2008) 0.98

Repeat sleeve gastrectomy compared with primary sleeve gastrectomy: a single-center, matched case study. Obes Surg (2012) 0.98

MR cholangiopancreatography versus endoscopic sonography in suspected common bile duct lithiasis: a prospective, comparative study. AJR Am J Roentgenol (2005) 0.97

Management of patients with carcinoma of the right colon invading the duodenum or pancreatic head. Int J Colorectal Dis (2008) 0.96

Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg (2003) 0.96

Groove pancreatitis and pancreatic heterotopia in the minor duodenal papilla. Pancreas (2005) 0.95

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm Bowel Dis (2014) 0.95

Three-dimensional computed tomography analysis of the left gastric vein in a pancreatectomy. HPB (Oxford) (2012) 0.95

Dynamic measurements of total hepatic blood flow with Phase Contrast MRI. Eur J Radiol (2008) 0.94

Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study. J Clin Gastroenterol (2005) 0.93

Injury to the liver and spleen after diagnostic ERCP. Can J Anaesth (2002) 0.93

Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. Pancreas (2009) 0.91

Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice. J Gastroenterol Hepatol (2009) 0.90

Rectal stenosis caused by foreign body reaction to sodium polystyrene sulfonate crystals (Kayexalate). Ann Diagn Pathol (2007) 0.90

Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study. Am J Gastroenterol (2013) 0.89

Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study. Inflamm Bowel Dis (2011) 0.89

Limits and benefits of exclusive transthoracic hepatectomy approach for patients with hepatocellular carcinoma. Hepatogastroenterology (2002) 0.88

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease. Inflamm Bowel Dis (2012) 0.88

Retracted Sinistroposition of the gallbladder and common bile duct. Hepatobiliary Pancreat Dis Int (2005) 0.88

Frey procedure in the treatment of chronic pancreatitis: short-term results. Pancreas (2006) 0.87

Feasibility of the Glissonian approach during right hepatectomy. HPB (Oxford) (2013) 0.87

Removal of hepatocellular carcinoma extending in the right atrium without extracorporal bypass. J Am Coll Surg (2002) 0.86

Two-year results on morbidity, weight loss and quality of life of sleeve gastrectomy as first procedure, sleeve gastrectomy after failure of gastric banding and gastric banding. Obes Surg (2009) 0.86

Does use of a metallic colon stent as a bridge to surgery modify the pathology data in patients with colonic obstruction? A case-matched study. Surg Endosc (2013) 0.86

Pathology report assessment of incidental gallbladder carcinoma diagnosed from cholecystectomy specimens: results of a French multicentre survey. Dig Liver Dis (2013) 0.85

Patients with brain metastases from colorectal cancer are not condemned. Anticancer Res (2013) 0.85

Cirrhosis should not be considered as an absolute contraindication for pancreatoduodenectomy. Hepatogastroenterology (2012) 0.84

Noninvasive diagnosis of large esophageal varices by Fibroscan: strong influence of the cirrhosis etiology. Alcohol Clin Exp Res (2010) 0.84

A comparative study of surgery and endoscopy for the treatment of bile duct stricture in patients with chronic pancreatitis. Surg Endosc (2012) 0.83

Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery. Am J Surg Pathol (2004) 0.83

The duodenal fossae: anatomic study and clinical correlations. Surg Radiol Anat (2005) 0.83

Complications of portal hypertension in adults: a French consensus. Eur J Gastroenterol Hepatol (2005) 0.83

Laparoscopic Versus Open Surgery for Gastric Gastrointestinal Stromal Tumors: What Is the Impact on Postoperative Outcome and Oncologic Results? Ann Surg (2015) 0.83

What to do when it is technically impossible to perform laparoscopic sleeve gastrectomy. Obes Surg (2014) 0.81

Does longitudinal sleeve gastrectomy have a family "halo effect"? A case-matched study. Surg Endosc (2013) 0.81

Gastrointestinal bleeding complication of gastric fistula after sleeve gastrectomy: consider pseudoaneurysms. Surg Endosc (2013) 0.81

Heterogeneous sensitivity of hepatocellular carcinoma to sorafenib revealed by the short-term culture of tumor fragments. Anticancer Res (2013) 0.81

Technique of open laparoscopy for supramesocolic surgery in obese patients. Surg Endosc (2010) 0.81

[Bariatric surgery in the treatment of severe obesity]. Rev Prat (2009) 0.81

Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus. PLoS One (2013) 0.81

Efficacy of the double-pigtail stent as a conservative treatment for grade B pancreatic fistula after pancreatoduodenectomy with pancreatogastric anastomosis. Surg Endosc (2013) 0.80

Management of persistent pancreatic fistula after pancreatoduodenectomy. Am Surg (2014) 0.80